E-MEXP-1421 - Transcription profiling by array of liver from rats treated with furan to study furan-induced cholangiofibrosis

Released on 1 April 2008, last updated on 2 May 2014
Rattus norvegicus
Samples (8)
Array (1)
Protocols (7)
Male Sprague Dawley Crl CD BR rats (190-240g, 6-8 weeks old), were obtained from Charles River, UK. They were given access to R&M No.1 diet and tap water ad libitum. Animals were housed 5/sex in solid bottom cages maintained at 21oC +/- 2oC, 12 h light and 12 h dark. All animals were acclimatised for at least 5 days prior to commencement of the study. Furan (CAS 110-00-9, Sigma-Aldrich Co. Ltd, >99 % pure was prepared in corn oil vehicle on the day of use and stored in sealed brown bottles. Furan was administered orally via gavage in corn oil at 30mg/kg (5 daily doses per week). Animals (n=5) were removed and sampled after 3 months of furan treatment. An off-dose recovery group was included at the 3 month time point (1 month off-dose) to enable assessment of lesion reversibility.
Experiment types
transcription profiling by array, co-expression, compound treatment, in vivo
Investigation descriptionE-MEXP-1421.idf.txt
Sample and data relationshipE-MEXP-1421.sdrf.txt
Raw data (1)E-MEXP-1421.raw.1.zip
Processed data (1)E-MEXP-1421.processed.1.zip
Array designA-AFFY-18.adf.txt
R ExpressionSetE-MEXP-1421.eSet.r